A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone
Berenson, James R, Limon, Andrea, Rice, Stephanie, Safaie, Tahmineh, Boccia, Ralph, Yang, Honghao, Moezi, Mehdi M., Lim, Stephen, Schwartz, Gary, Eshaghian, Shahrooz, Brobeck, Matthew, Swift, Regina, Eades, Benjamin M., Bujarski, Sean, Sebhat, Yohana, Ray, Rudra, Kim, Susanna, Vescio, Robert Allen
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone
Berenson, James R., Limon, Andrea, Rice, Stephanie, Safaie, Tahmineh, Boccia, Ralph, Yang, Honghao, Moezi, Mehdi, Lim, Stephen, Schwartz, Gary, Eshaghian, Shahrooz, Brobeck, Matthew, Swift, Regina, Eades, Benjamin M., Bujarski, Sean, Sebhat, Yohana, Ray, Rudra, Kim, Susanna, Del Dosso, Ashley, Vescio, Robert
Published in Targeted oncology (01.05.2024)
Published in Targeted oncology (01.05.2024)
Get full text
Journal Article